<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04278456</url>
  </required_header>
  <id_info>
    <org_study_id>EBYU 88</org_study_id>
    <nct_id>NCT04278456</nct_id>
  </id_info>
  <brief_title>Postpartum Depression</brief_title>
  <official_title>The Effect of the Anesthesia Modality Used in Women Giving Birth Under Caesarian Section on Postpartum Depression and/or Postoperative Melatonin Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erzincan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erzincan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our aim was to diagnose and initiate early treatment for postpartum depression by detecting
      the changes of melatonin levels in c-sections with different antesthesia modalities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 21, 2020</start_date>
  <completion_date type="Anticipated">July 21, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 21, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Week</target_duration>
  <primary_outcome>
    <measure>edinburgh depression scale</measure>
    <time_frame>5 months</time_frame>
    <description>below 12 is associated with depression</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Postpartum Depression</condition>
  <condition>Melatonin</condition>
  <arm_group>
    <arm_group_label>general anesthesia</arm_group_label>
    <description>c-section with general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>spinal anesthesia</arm_group_label>
    <description>c-section with spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>epidural anesthesia</arm_group_label>
    <description>c-section with epidural anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>postpartum depression</intervention_name>
    <description>melatonin levels in c-sections with different anesthesia modalities.</description>
    <arm_group_label>epidural anesthesia</arm_group_label>
    <arm_group_label>general anesthesia</arm_group_label>
    <arm_group_label>spinal anesthesia</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant women that will give birth by c-section (using general or regional anesthesia)
        aged between 18-45 years will be included to our study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant women c-section (using general or regional anesthesia) aged between 18-45
             years

        Exclusion Criteria:

          -  age under 18 or above 45, history of smoking, a diagnosis with mental retardation,
             psychiatric patients, use of antipsychotics or antidepressants, patients with sleeping
             disorders, hormone replacement theraphy patients.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>aged between 18-45 years</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Remziye Ayşenur NALBANT</last_name>
    <role>Principal Investigator</role>
    <affiliation>ERZİNCAN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DİDEM ONK</last_name>
    <phone>05053856322</phone>
    <email>d.hesapdar@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Erzincan Byu</name>
      <address>
        <city>Erzincan</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DİDEM ONK</last_name>
      <phone>05053856322</phone>
      <email>d.hesapdar@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Andersen LP, Werner MU, Rosenberg J, Gögenur I. A systematic review of peri-operative melatonin. Anaesthesia. 2014 Oct;69(10):1163-71. doi: 10.1111/anae.12717. Epub 2014 May 19. Review.</citation>
    <PMID>24835540</PMID>
  </results_reference>
  <results_reference>
    <citation>Maitra S, Baidya DK, Khanna P. Melatonin in perioperative medicine: Current perspective. Saudi J Anaesth. 2013 Jul;7(3):315-21. doi: 10.4103/1658-354X.115316. Review.</citation>
    <PMID>24015137</PMID>
  </results_reference>
  <results_reference>
    <citation>Dianatkhah M, Ghaeli P, Hajhossein Talasaz A, Karimi A, Salehiomran A, Bina P, Jalali A, Ghaffary S, Shahmansouri N, Vejdani S. Evaluating the Potential Effect of Melatonin on the post-Cardiac Surgery Sleep Disorder. J Tehran Heart Cent. 2015 Jul 3;10(3):122-8.</citation>
    <PMID>26697084</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>February 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2020</study_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erzincan University</investigator_affiliation>
    <investigator_full_name>REMZIYE AYSENUR NALBANT</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression, Postpartum</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

